Assembly Biosciences (ASMB) FCF Margin (QoQ) (2017 - 2026)
Assembly Biosciences (ASMB) FCF Margin (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15,271.00 |
| Mar 31, 2026 | -30,275.00 |
| Dec 31, 2025 | 17,412.00 |
| Sep 30, 2025 | 3,344.00 |
| Jun 30, 2025 | 7,476.00 |
| Mar 31, 2025 | -24,332.00 |
| Dec 31, 2024 | 21,717.00 |
| Sep 30, 2024 | -2,212.00 |
| Jun 30, 2024 | 11,710.00 |
| Mar 31, 2024 | -135,647.00 |
| Dec 31, 2020 | -247,237.00 |
| Sep 30, 2020 | 9,986.00 |
| Jun 30, 2020 | 55,314.00 |
| Mar 31, 2020 | -18,643.00 |
| Dec 31, 2019 | 8,404.00 |
| Sep 30, 2019 | 16,803.00 |
| Jun 30, 2019 | -11,025.00 |
| Mar 31, 2019 | -11,927.00 |
| Dec 31, 2018 | -6,336.00 |
| Sep 30, 2018 | 11,139.00 |